nach oben

Neuropsychology Review

Erschienen in:

01.12.2007

Neuropsychological and Behavioral Effects of Antiepilepsy Drugs

verfasst von: David W. Loring, Susan Marino, Kimford J. Meador

Erschienen in: Neuropsychology Review | Ausgabe 4/2007

Einloggen, um Zugang zu erhalten

Abstract

Antiepilepsy drugs work by decreasing neuronal irritability, which may also result in the non-desired side effect of decreased neuropsychological function. In addition to cognitive side effects, antiepilepsy drugs (AEDs) may be associated with behavioral effects which may range from irritability and hyperactivity to positive psychotropic effects on mood. There have been many new medications released since the 1990s, and although they tend to have more favorable side effect profiles compared to their older counterparts, there continues to be a risk of decreased cognitive function with the majority of these agents. The effects of in utero antiepilepsy drug exposure are increasingly being investigated, and differential drug risk is beginning to be described for both anatomic and cognitive outcomes. Patients with epilepsy undergoing neuropsychological evaluations are commonly on AEDs, and it is important for the clinician to recognize the potential contribution of AED therapy to neuropsychological profiles. The present article serves to provide an overview of our current understanding regarding the risks of antiepilepsy drug use for both cognitive and behavioral side effects.

Adab, N., Jacoby, A., Smith, D., & Chadwick, D. (2001). Additional educational needs in children born to mothers with epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 70, 15–21.CrossRef

Adab, N., Kini, U., Vinten, J., Ayres, J., Baker, G., & Clayton-Smith, J., et al. (2004). The longer term outcome of children born to mothers with epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 75(11), 1575–1583.CrossRef

Adams, J., Vorhees, C. V., & Middaugh, L. D. (1990). Developmental neurotoxicity of anticonvulsants: Human and animal evidence on phenytoin. Neurotoxicology & Teratology, 12(3), 203–214.CrossRef

Aikia, M., Jutila, L., Salmenpera, T., Mervaala, E., & Kalviainen, R. (2006a). Comparison of the Cognitive effects of tiagabine and carbamazepine as monotherapy in newly diagnosed adult patients with partial epilepsy: Pooled analysis of two long-term, randomized, follow-up studies. Epilepsia, 47(7), 1121–1127.PubMedCrossRef

Aikia, M., Jutila, L., Salmenpera, T., Mervaala, E., & Kalviainen, R. (2006b). Long-term effects of tiagabine monotherapy on cognition and mood in adult patients with chronic partial epilepsy. Epilepsy & Behavior, 8(4), 750–755.CrossRef

Aikia, M., Kalviainen, R., Sivenius, J., Halonen, T., & Riekkinen, P. J. (1992). Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: One year follow-up. Epilepsy Research, 11(3), 199–203.PubMedCrossRef

Aldenkamp, A. P., Arends, J., Bootsma, H. P., Diepman, L., Hulsman, J., & Lambrechts, D., et al. (2002). Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia, 43(1), 19–26.PubMedCrossRef

Aldenkamp, A. P., Baker, G., Mulder, O. G., Chadwick, D., Cooper, P., & Doelman, J., et al. (2000). A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia, 41(9), 1167–1178.PubMedCrossRef

Aldenkamp, A. P., Dreifuss, F. E., Renier, W. O., & Suumeijer, P. B. M. (1995). Epilepsy in children and adolescents. Boca Raton, FL: CRC Press.

Anonymous (1992). Correction. New England Journal of Medicine, 326, 144.CrossRef

Artama, M., Auvinen, A., Raudaskoski, T., Isojarvi, I., & Isojarvi, J. (2005). Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology, 64(11), 1874–1878.PubMedCrossRef

Berent, S., Sackellares, J. C., Giordani, B., Wagner, J. G., Donofrio, P. D., & Abou-Khalil, B. (1987). Zonisamide (CI-912) and cognition: Results from preliminary study. Epilepsia, 28(1), 61–67.PubMedCrossRef

Bittigau, P., Sifringer, M., & Ikonomidou, C. (2003a). Antiepileptic drugs and apoptosis in the developing brain. Annals of the New York Academy of Sciences, 993, 103–114.PubMed

Bittigau, P., Sifringer, M., & Ikonomidou, C. (2003b). Antiepileptic drugs and apoptosis in the developing brain. Annals of the New York Academy of Sciences, 993(1), 103–114.PubMed

Blum, D., Meador, K., Biton, V., Fakhoury, T., Shneker, B., & Chung, S., et al. (2006). Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology, 67(3), 400–406.PubMedCrossRef

Bootsma, H. P. R., Ricker, L., Diepman, L., Gehring, J., Hulsman, J., Lambrechts, D., et al. (2007). Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison. Seizure, In Press, Corrected Proof.

Brodie, M. J., Richens, A., & Yuen, A. W. (1995). Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK lamotrigine/carbamazepine monotherapy trial group. Lancet, 345(8948), 476–479.PubMedCrossRef

Buchanan, N. (1995). The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability. Seizure, 4(3), 233–236.PubMedCrossRef

Carpay, J. A., Aldenkamp, A. P., & van Donselaar, C. A. (2005). Complaints associated with the use of antiepileptic drugs: results from a community-based study. Seizure, 14(3), 198–206.PubMedCrossRef

Chadwick, D., Anhut, H., Greiner, M., Alexander, J., Murray, G., & Garofalo, E., et al. (1998). A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology, 51(5), 1282–1288.PubMed

Chen, Y., Chi Chow, J., & Lee, I. (2001). Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Research, 44(1), 65–70.PubMedCrossRef

Cohen, A. F., Ashby, L., Crowley, D., Land, G., Peck, A. W., & Miller, A. A. (1985). Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. British Journal of Clinical Pharmacology, 20(6), 619–629.PubMed

Cramer, J. A., De Rue, K., Devinsky, O., Edrich, P., & Trimble, M. R. (2003). A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy and Behavior, 4(2), 124–132.PubMedCrossRef

Cumming, R. G., & Le Couteur, D. G. (2003). Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs, 17(11), 825–837.PubMedCrossRef

Cunnington, M., & Tennis, P. (2005). Lamotrigine and the risk of malformations in pregnancy. Neurology, 64(6), 955–960.PubMed

Curran, H. V., & Java, R. (1993). Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. European Journal of Clinical Pharmacology, 44(6), 529–533.PubMedCrossRef

Dodrill, C. B., Arnett, J. L., Deaton, R., Lenz, G. T., & Sommerville, K. W. (2000). Tiagabine versus phenytoin and carbamazepine as add-on therapies: Effects on abilities, adjustment, and mood. Epilepsy Research, 42(2–3), 123–132.PubMedCrossRef

Dodrill, C. B., Arnett, J. L., Hayes, A. G., Garofalo, E. A., Greeley, C. A., & Greiner, M. J., et al. (1999). Cognitive abilities and adjustment with gabapentin: Results of a multisite study. Epilepsy Research, 35(2), 109–121.PubMedCrossRef

Dodrill, C. B., Arnett, J. L., Sommerville, K. W., & Shu, V. (1997). Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology, 48(4), 1025–1031.PubMed

Dodrill, C. B., Arnett, J. L., Sommerville, K. W., & Sussman, N. M. (1993). Evaluation of the effects of vigabatrin on cognitive abilities and quality of life in epilepsy. Neurology, 43(12), 2501–2507.PubMed

Dodrill, C. B., Arnett, J. L., Sommerville, K. W., & Sussman, N. M. (1995). Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia, 36(2), 164–173.PubMedCrossRef

Dodrill, C. B., & Troupin, A. S. (1991). Neuropsychological effects of carbamazepine and phenytoin: A reanalysis. Neurology, 41(1), 141–143.PubMed

Donati, F., Gobbi, G., Campistol, J., Rapatz, G., Daehler, M., & Sturm, Y., et al. (2006). Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology, 67(4), 679−682.PubMedCrossRef

Donati, F., Gobbi, G., Campistol, J., Rapatz, G., Daehler, M., Sturm, Y., et al. (2007). The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure, In Press, Corrected Proof.

Farwell, J. R., Lee, Y. J., Hirtz, D. G., Sulzbacher, S. I., Ellenberg, J. H., & Nelson, K. B. (1990). Phenobarbital for febrile seizures–effects on intelligence and on seizure recurrence. New England Journal of Medicine, 322(6), 364–369.PubMedCrossRef

Ferrie, C. D., Robinson, R. O., & Panayiotopoulos, C. P. (1996). Psychotic and severe behavioural reactions with vigabatrin: A review. Acta Neurologica Scandinavica, 93(1), 1–8.PubMed

Finnell, R. H., & Dansky, L. V. (1991). Parental epilepsy, anticonvulsant drugs, and reproductive outcome: Epidemiologic and experimental findings spanning three decades; 1: Animal studies. Reproductive Toxicology, 5(4), 281–299.PubMedCrossRef

Fisher, J. E., & Vorhees, C. V. (1992). Developmental toxicity of antiepileptic drugs: Relationship to postnatal dysfunction. Pharmacological Research, 26(3), 207–221.PubMedCrossRef

Fritz, N., Glogau, S., Hoffmann, J., Rademacher, M., Elger, C. E., & Helmstaedter, C. (2005). Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy & Behavior, 6(3), 373–381.CrossRef

Gaily, E., Kantola-Sorsa, E., Hiilesmaa, V., Isoaho, M., Matila, R., & Kotila, M., et al. (2004). Normal intelligence in children with prenatal exposure to carbamazepine. Neurology, 62(1), 28–32.PubMed

Garrard, J., Harms, S., Eberly, L.E., Leppik, I. E. (2007). In J. C. C. R. E. Ramsay, K. M. Kelly, I. E. Leppik, E. Perucca, & (Eds.) The neurobiology of epilepsy and aging Use of antiepileptic medications in nursing homes international review of neurobiology (vol. 81, pp. 165–182). San Diego: Academic.CrossRef

Garrard, J., Harms, S., Hardie, N., Eberly, L. E., Nitz, N., & Bland, P., et al. (2003). Antiepileptic drug use in nursing home admissions. Annals of Neurology, 54(1), 75–85.PubMedCrossRef

Gilliam, F. (2002). Optimizing health outcomes in active epilepsy. Neurology, 58(8 Suppl 5), S9–S20.PubMed

Gillham, R., Baker, G., Thompson, P., Birbeck, K., McGuire, A., & Tomlinson, L., et al. (1996). Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments. Epilepsy Research, 24(1), 47–55.PubMedCrossRef

Gillham, R. A., Blacklaw, J., McKee, P. J., & Brodie, M. J. (1993). Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 56(12), 1271–1275.CrossRef

Glauser, T. A. (2004). Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. Journal of Child Neurology, 19, S25–S38.PubMedCrossRef

Glauser, T. A., Gauer, L. J., Chen, L., & Group, L. N. P. S. (2004). Multicenter, double-blind, placebo-controlled trial of adjunctive levetiracetam (Keppra ®) therapy (up to 60 mg/kg/day) in pediatric patients with refractory partial epilepsy. Epilepsia, 45(Suppl 7), 186.

Glier, C., Dzietko, M., Bittigau, P., Jarosz, B., Korobowicz, E., & Ikonomidou, C. (2004). Therapeutic doses of topiramate are not toxic to the developing rat brain. Experimental Neurology, 187(2), 403–409.PubMedCrossRef

Gomer, B., Wagner, K., Frings, L., Saar, J., Carius, A., & Harle, M., et al. (2007). The influence of antiepileptic drugs on cognition: A comparison of levetiracetam with topiramate. Epilepsy & Behavior, 10(3), 486–494.CrossRef

Gross-Tsur, V., & Shalev, R. S. (2004). Reversible language regression as an adverse effect of topiramate treatment in children. Neurology, 62(2), 299–300.PubMed

Grunewald, R. A., Thompson, P. J., Corcoran, R., Corden, Z., Jackson, G. D., & Duncan, J. S. (1994). Effects of vigabatrin on partial seizures and cognitive function. Journal of Neurology, Neurosurgery & Psychiatry, 57(9), 1057–1063.

Hamilton, M. J., Cohen, A. F., Yuen, A. W., Harkin, N., Land, G., & Weatherley, B. C., et al. (1993). Carbamazepine and lamotrigine in healthy volunteers: Relevance to early tolerance and clinical trial dosage. Epilepsia, 34(1), 166–173.PubMedCrossRef

Herranz, J. L., Armijo, J. A., & Arteaga, R. (1988). Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children. Epilepsia, 29(6), 794–804.PubMedCrossRef

Hindmarch, I., Trick, L., & Ridout, F. (2005). A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers. Psychopharmacology, 183(2), 133–143.PubMedCrossRef

Kalviainen, R., Aikia, M., Mervaala, E., Saukkonen, A. M., Pitkanen, A., & Riekkinen Sr., P. J. (1996). Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Research, 25(3), 291–297.PubMedCrossRef

Kalviainen, R., Aikia, M., Saukkonen, A. M., Mervaala, E., & Riekkinen, P. J. S. (1995). Vigabatrin vs carbamazepine monotherapy in patients with newly diagnosed epilepsy. A randomized, controlled study. Archives of Neurology, 52(10), 989–996.PubMed

Katz, I., Kim, J., Gale, K., & Kondratyev, A. (2006). Effects of lamotrigine on apoptotic cell death in the neonatal rat brain. http://aesnet.org/Visitors/AnnualMeeting/Abstracts/dsp_Abstract.cfm?id=6623.

Kim, J., Kondratyev, A., & Gale, K. (2006). Enhancement of phenytoin-induced neuronal death in neonatal rats by AEDs that do not induce neuronal death when given alone. http://aesnet.org/Visitors/AnnualMeeting/Abstracts/dsp_Abstract.cfm?id=6621.

Kim, J., Lapides, D., Kondratyev, A., & Gale, K. (2004). Repeated brief seizures in neonatal rats attenuates programmed cell death induced by MK-801. Epilepsia, 45(Suppl 7), 209.

Kockelmann, E., Elger, C. E., & Helmstaedter, C. (2003). Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of Topiramate in epilepsy patients. Epilepsy Research, 54(2–3), 171–178.PubMedCrossRef

Kossoff, E. H., Bergey, G. K., Freeman, J. M., & Vining, E. P. (2001). Levetiracetam psychosis in children with epilepsy. Epilepsia, 42(12), 1611–1613.PubMedCrossRef

Kwan, P., & Brodie, M. J. (2001a). Effectiveness of first antiepileptic drug. Epilepsia, 42(10), 1255–1260.PubMedCrossRef

Kwan, P., & Brodie, M. J. (2001b). Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet, 357(9251), 216–222.PubMedCrossRef

Lackner, T. E., Cloyd, J. C., Thomas, L. W., & Leppik, I. E. (1998). Antiepileptic drug use in nursing home residents: Effect of age, gender, and comedication on patterns of use. Epilepsia, 39(10), 1083–1087.PubMedCrossRef

Leach, J. P., Girvan, J., Paul, A., & Brodie, M. J. (1997). Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. Journal of Neurology, Neurosurgery & Psychiatry, 62(4), 372–376.

Leach, M. J., Marden, C. M., & Miller, A. A. (1986). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia, 27(5), 490–497.PubMedCrossRef

Lee, H.-W., Jung, D.-K., Suh, C.-K., Kwon, S.-H., & Park, S.-P. (2006). Cognitive effects of low-dose topiramate monotherapy in epilepsy patients: A 1-year follow-up. Epilepsy & Behavior, 8(4), 736–741.CrossRef

Lee, D. O., Steingard, R. J., Cesena, M., Helmers, S. L., Riviello, J. J., & Mikati, M. A. (1996). Behavioral side effects of gabapentin in children. Epilepsia, 37(1), 87–90.PubMedCrossRef

Lee, S., Sziklas, V., Andermann, F., Farnham, S., Risse, G., & Gustafson, M., et al. (2003). The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia, 44(3), 339–347.PubMedCrossRef

Lennox, W. G. (1942). Brain injury, drugs and environment as causes of mental decay in epilepsy. American Journal of Psychiatry, 99, 174–180.

Loring, D. W., & Meador, K. J. (2004). Cognitive side effects of antiepileptic drugs in children. Neurology, 62, 872–877.PubMed

Loring, D. W., Meador, K. J., Williamson, D. J., Wiegand, F., & Hulihan, J. (2007). Topiramate dose effects on neuropsychological function: Analysis from a randomized double-blind placebo-controlled study. Paper presented at the annual meeting of the American Epilepsy Society, Philadelphia, PA, December.

Mackay, F. J., Wilton, L. V., Pearce, G. L., Freemantle, S. N., & Mann, R. D. (1997). Safety of long-term lamotrigine in epilepsy. Epilepsia, 38(8), 881–886.PubMedCrossRef

Manthey, D., Asimiadou, S., Stefovska, V., Kaindl, A. M., Fassbender, J., & Ikonomidou, C., et al. (2005). Sulthiame but not levetiracetam exerts neurotoxic effect in the developing rat brain. Experimental Neurology, 193(2), 497–503.PubMedCrossRef

Marson, A. G., Al-Kharusi, A. M., Alwaidh, M., Appleton, R., Baker, G. A., & Chadwick, D. W., et al. (2007). The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: An unblinded randomised controlled trial. The Lancet, 369(9566), 1016–1026.CrossRef

Martin, R., Kuzniecky, R., Ho, S., Hetherington, H., Pan, J., & Sinclair, K., et al. (1999). Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology, 52(2), 321–327.PubMed

Martin, R., Meador, K., Turrentine, L., Faught, E., Sinclair, K., & Kuzniecky, R., et al. (2001). Comparative cognitive effects of carbamazepine and gabapentin in healthy senior adults. Epilepsia, 42(6), 764–771.PubMedCrossRef

Mattson, R., Cramer, J., Collins, J., Smith, D., Delgado-Escueta, A., & Browne, T., et al. (1985). Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New England Journal of Medicine, 313(3), 145–151.PubMedCrossRef

Meador, K. J. (2005). Cognitive effects of epilepsy and of antiepileptic medications. In E. Wyllie (Ed.) The treatment of epilepsy ((pp. 1215–1226)4th ed.). Baltimore, M.D.: Williams & Wilkins.

Meador, K. J., & Baker, G. A. (1997). Behavioral and cognitive effects of lamotrigine. Journal of Child Neurology, 12(Suppl 1), S44–S47.PubMedCrossRef

Meador, K. J., Baker, G. A., Finnell, R. H., Kalayjian, L. A., Liporace, J. D., & Loring, D. W., et al. (2006). In utero antiepileptic drug exposure: Fetal death and malformations. Neurology, 67(3), 407–412.PubMedCrossRef

Meador, K. J., Browning, N., Cohen, M. J., Kalayjian, L. A., Liporace, J., & Pennell, P. B., et al. (2007a). Cognitive outcomes at 2 years old in children of women with epilepsy differ as function of in utero antiepileptic drug. Neurology, 68(Suppl 1), A337.

Meador, K. J., Gevins, A., Loring, D. W., McEvoy, L. K., Ray, P. G., Smith, M. E., et al. (2007b). Neuropsychological and neurophysiological effects of carbamazepine and levetiracetam. Neurology, in press.

Meador, K. J., Loring, D. W., Abney, O. L., Allen, M. E., Moore, E. E., & Zamrini, E. Y., et al. (1993). Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia, 34(1), 153–157.PubMedCrossRef

Meador, K. J., Loring, D. W., Allen, M. E., Zamrini, E. Y., Moore, E. E., & Abney, O. L., et al. (1991). Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology, 41(10), 1537–1540.PubMed

Meador, K. J., Loring, D. W., Huh, K., Gallagher, B. B., & King, D. W. (1990). Comparative cognitive effects of anticonvulsants. Neurology, 40(3 Pt 1), 391–394.PubMed

Meador, K. J., Loring, D. W., Hulihan, J. F., Kamin, M., & Karim, R. (2003). Differential cognitive and behavioral effects of topiramate and valproate. Neurology, 60(9), 1483–1488.PubMed

Meador, K. J., Loring, D. W., Moore, E. E., Thompson, W. O., Nichols, M. E., & Oberzan, R. E., et al. (1995). Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults. Neurology, 45(8), 1494–1499.PubMed

Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., & Nichols, M. E., et al. (1999). Differential cognitive effects of carbamazepine and gabapentin. Epilepsia, 40(9), 1279–1285.PubMedCrossRef

Meador, K. J., Loring, D. W., Ray, P. G., Murro, A. M., King, D. W., & Perrine, K. R., et al. (2001). Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology, 56, 1177–1182.PubMed

Meador, K. J., Loring, D. W., Vahle, V. J., Ray, P. G., Werz, M. A., & Fessler, A. J., et al. (2005). Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers. Neurology, 64(12), 2108–2114.PubMedCrossRef

Mecarelli, O., Vicenzini, E., Pulitano, P., Vanacore, N., Romolo, F. S., & Di Piero, V., et al. (2004). Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers. Annals of Pharmacotherapy, 38(11), 1816–1822.PubMedCrossRef

Miller, N. R., Johnson, M. A., Paul, S. R., Girkin, C. A., Perry, J. D., & Endres, M., et al. (1999). Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiologic findings. Neurology, 53(9), 2082.PubMed

Mortimore, C., Trimble, M., & Emmers, E. (1998). Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure, 7(5), 359–364.PubMedCrossRef

Mula, M., Trimble, M. R., Lhatoo, S. D., & Sander, J. W. A. S. (2003). Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia, 44(5), 659–663.PubMedCrossRef

Neyens, L. G., Alpherts, W. C., & Aldenkamp, A. P. (1995). Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 19(3), 411–419.CrossRef

Pellock, J. M., Faught, E., Leppik, I. E., Shinnar, S., & Zupanc, M. L. (2006). Felbamate: Consensus of current clinical experience. Epilepsy Research, 71(2–3), 89–101.PubMedCrossRef

Pennell, P. B. (2004). Pregnancy in women who have epilepsy. Neurologic Clinics: Neurology Illnesses and Pregnancy, 22(4), 799–820.

Placidi, F., Marciani, M. G., Diomedi, M., Scalise, A., Pauri, F., & Giacomini, P., et al. (2000). Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy. Acta Neurologica Scandinavica, 102(2), 81–86.PubMedCrossRef

Pressler, R. M., Binnie, C. D., Coleshill, S. G., Chorley, G. A., & Robinson, R. O. (2006). Effect of lamotrigine on cognition in children with epilepsy. Neurology, 66(10), 1495–1499.PubMedCrossRef

Prevey, M. L., Delaney, R. C., Cramer, J. A., Cattanach, L., Collins, J. F., & Mattson, R. H. (1996). Effect of valproate on cognitive functioning. Comparison with carbamazepine. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Archives of Neurology, 53(10), 1008–1016.PubMed

Pulliainen, V., & Jokelainen, M. (1994). Effects of phenytoin and carbamazepine on cognitive functions in newly diagnosed epileptic patients. Acta Neurologica Scandinavica, 89(2), 81–86.PubMedCrossRef

Reinisch, J. M., Sanders, S. A., Mortensen, E. L., & Rubin, D. B. (1995). In utero exposure to phenobarbital and intelligence deficits in adult men. Jama, 274(19), 1518–1525.PubMedCrossRef

Rowan, A. J., Ramsay, R. E., Collins, J. F., Pryor, F., Boardman, K. D., & Uthman, B. M., et al. (2005). New onset geriatric epilepsy: A randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology, 64(11), 1868–1873.PubMedCrossRef

Saletu, B., Grunberger, J., Linzmayer, L., Schwartz, L. L., Haegele, K. D., & Schechter, P. J. (1986). Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor. International Journal of Psychophysiology, 4, 63–80.PubMedCrossRef

Salinsky, M. C., Binder, L. M., Oken, B. S., Storzbach, D., Aron, C. R., & Dodrill, C. B. (2002). Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia, 43(5), 482–490.PubMedCrossRef

Salinsky, M. C., Spencer, D. C., Oken, B. S., & Storzbach, D. (2004). Effects of oxcarbazepine and phenytoin on the EEG and cognition in healthy volunteers. Epilepsy & Behavior, 5(6), 894–902.CrossRef

Salinsky, M. C., Storzbach, D., Spencer, D. S., & Landry, T. (2005a). Topiramate effects on the EEG, alertness, and cognition: A unique profile of AED neurotoxicity. Epilepsia, 46(Suppl. 8), 185.

Salinsky, M. C., Storzbach, D., Spencer, D. C., Oken, B. S., Landry, T., & Dodrill, C. B. (2005b). Effects of topiramate and gabapentin on cognitive abilities in healthy volunteers. Neurology, 64(5), 792–798.PubMed

Schmidt, D., & Elger, C. E. (2004). What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy & Behavior, 5(5), 627–635.CrossRef

Smith, D., Baker, G., Davies, G., Dewey, M., & Chadwick, D. W. (1993). Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia, 34(2), 312–322.PubMedCrossRef

Smith Jr., K. R., Goulding, P. M., Wilderman, D., Goldfader, P. R., Holterman-Hommes, P., & Wei, F. (1994). Neurobehavioral effects of phenytoin and carbamazepine in patients recovering from brain trauma: a comparative study. Archives of Neurology, 51(7), 653–660.PubMed

Sulzbacher, S., Farwell, J. R., Temkin, N., Lu, A. S., & Hirtz, D. G. (1999). Late cognitive effects of early treatment with phenobarbital. Clinical Pediatrics, 38(7), 387–394.PubMedCrossRef

Sveinbjornsdottir, S., Sander, J. W., Patsalos, P. N., Upton, D., Thompson, P. J., & Duncan, J. S. (1994). Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure, 3(1), 29–35.PubMedCrossRef

Thompson, P. J., Baxendale, S. A., Duncan, J. S., & Sander, J. W. (2000). Effects of topiramate on cognitive function. Journal of Neurology, Neurosurgery & Psychiatry, 69, 636–641.CrossRef

Uvebrant, P., & Bauzienè, R. (1994). Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits. Neuropediatrics, 25(6), 284–289.PubMed

Vajda, F. J. E., & Eadie, M. J. (2005). Maternal valproate dosage and foetal malformations. Acta Neurologica Scandinavica, 112(3), 137–143.PubMedCrossRef

Vermeulen, J., & Aldenkamp, A. P. (1995). Cognitive side-effects of chronic antiepileptic drug treatment: A review of 25 years of research. Epilepsy Research, 22(2), 65–95.PubMedCrossRef

Vinten, J., Adab, N., Kini, U., Gorry, J., Gregg, J., & Baker, G. A., et al. (2005). Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology, 64(6), 949–954.PubMed

Weintraub, D., Buchsbaum, R., Resor Jr., S. R., & Hirsch, L. J. (2007). Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy. Epilepsy & Behavior, 10(1), 105–110.CrossRef

Wide, K., Winbladh, B., & Kallen, B. (2004). Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepine and valproic acid: A nation-wide, population-based register study. Acta Paediatrica, 93(2), 174–176.PubMedCrossRef

Wolf, S. M., & Forsythe, A. (1978). Behavior disturbance, phenobarbital, and febrile seizures. Pediatrics, 61(5), 728–731.PubMed

Wolf, S. M., Forsythe, A., Stunden, A. A., Friedman, R., & Diamond, H. (1981). Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics, 68(6), 820–823.PubMed

Wolf, S. M., Shinnar, S., Kang, H., Gil, K. B., & Moshe, S. L. (1995). Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia, 36(12), 1203–1205.PubMedCrossRef

Wong, I. C., Mawer, G. E., & Sander, J. W. (2001). Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom. Epilepsia, 42(2), 237–244.PubMedCrossRef

Wyszynski, D. F., Nambisan, M., Surve, T., Alsdorf, R. M., Smith, C. R., & Holmes, L. B., et al. (2005). Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology, 64(6), 961–965.PubMed

Titel: Neuropsychological and Behavioral Effects of Antiepilepsy Drugs
verfasst von: David W. Loring
Susan Marino
Kimford J. Meador
Publikationsdatum: 01.12.2007
Verlag: Springer US
Erschienen in: Neuropsychology Review / Ausgabe 4/2007
Print ISSN: 1040-7308
Elektronische ISSN: 1573-6660
DOI: https://doi.org/10.1007/s11065-007-9043-9

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2007

Epilepsy and Neuropsychology: Past, Present, and Future

Psychogenic Nonepileptic Seizures

Recent Innovative Studies of Memory in Temporal Lobe Epilepsy

Neuropsychological Features of Lesion-related Epilepsy in Adults: An Overview

Cognitive Progression in Epilepsy